• Something wrong with this record ?

Space GlucoseControl system for blood glucose control in intensive care patients--a European multicentre observational study

J. Blaha, B. Barteczko-Grajek, P. Berezowicz, J. Charvat, J. Chvojka, T. Grau, J. Holmgren, U. Jaschinski, P. Kopecky, J. Manak, M. Moehl, J. Paddle, M. Pasculli, J. Petersson, S. Petros, D. Radrizzani, V. Singh, J. Starkopf,

. 2016 ; 16 (-) : 8. [pub] 20160122

Language English Country England, Great Britain

Document type Clinical Trial, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

BACKGROUND: Glycaemia control (GC) remains an important therapeutic goal in critically ill patients. The enhanced Model Predictive Control (eMPC) algorithm, which models the behaviour of blood glucose (BG) and insulin sensitivity in individual ICU patients with variable blood samples, is an effective, clinically proven computer based protocol successfully tested at multiple institutions on medical and surgical patients with different nutritional protocols. eMPC has been integrated into the B.Braun Space GlucoseControl system (SGC), which allows direct data communication between pumps and microprocessor. The present study was undertaken to assess the clinical performance and safety of the SGC for glycaemia control in critically ill patients under routine conditions in different ICU settings and with various nutritional protocols. METHODS: The study endpoints were the percentage of time the BG was within the target range 4.4 - 8.3 mmol.l(-1), the frequency of hypoglycaemic episodes, adherence to the advice of the SGC and BG measurement intervals. BG was monitored, and insulin was given as a continuous infusion according to the advice of the SGC. Nutritional management (enteral, parenteral or both) was carried out at the discretion of each centre. RESULTS: 17 centres from 9 European countries included a total of 508 patients, the median study time was 2.9 (1.9-6.1) days. The median (IQR) time-in-target was 83.0 (68.7-93.1) % of time with the mean proposed measurement interval 2.0 ± 0.5 hours. 99.6% of the SGC advices on insulin infusion rate were accepted by the user. Only 4 episodes (0.01% of all BG measurements) of severe hypoglycaemia <2.2 mmol.l(-1) in 4 patients occurred (0.8%; 95% CI 0.02-1.6%). CONCLUSION: Under routine conditions and under different nutritional protocols the Space GlucoseControl system with integrated eMPC algorithm has exhibited its suitability for glycaemia control in critically ill patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT01523665.

Critical Care Services Department of Anaesthetics West Suffollk Hospital NHS Trust Bury St Edmunds UK

Department of Anaesthesiology and Intensive Care Medicine Capio Hospital Sur Madrid Spain

Department of Anaesthesiology and Intensive Care Medicine County Hospital Ryhov Jönköping Sweden

Department of Anaesthesiology and Intensive Care Medicine Vejle Hospital Vejle Denmark

Department of Anaesthesiology and Intensive Care Tartu University Hospital Tartu Estonia

Department of Anaesthesiology and Intensive Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague U Nemocnice 2 128 08 Prague 2 Czech Republic

Department of Anaesthesiology and Intensive Therapy Wroclaw Medical University Wroclaw Poland

Department of Anaesthesiology and Surgical Intensive Care Medicine Klinikum Augsburg Augsburg Germany

Department of Anesthesiology and Intensive Care Karolinska University Hospital Solna Stockholm Sweden

Department of Anesthesiology and Intensive Care Legnano Hospital Legnano Italy

Department of Cardiothoracic Anaesthesia and Intensive Care Unit University Hospital University of Copenhagen Copenhagen Denmark

Department of Internal Medicine 3 Metabolism and Gerontology University Hospital Hradec Kralove Hradec Kralove Czech Republic

Department of Surgical and Intensive Medicine Siena University Hospital Siena Italy

Intensive Care Department Royal Cornwall Hospital Truro UK

Internal Medicine Clinic University Hospital in Motol Prague Czech Republic

Medical Department 1 Faculty of Medicine in Pilsen Charles University Prague and University Hospital in Pilsen Pilsen Czech Republic

Medical ICU University Hospital Leipzig Leipzig Germany

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000590
003      
CZ-PrNML
005      
20170113095347.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12871-016-0175-4 $2 doi
024    7_
$a 10.1186/s12871-016-0175-4 $2 doi
035    __
$a (PubMed)26801983
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Blaha, Jan $u Department of Anaesthesiology and Intensive Medicine, 1st Faculty of Medicine, Charles University and General University Hospital Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. jan.blaha@lf1.cuni.cz.
245    10
$a Space GlucoseControl system for blood glucose control in intensive care patients--a European multicentre observational study / $c J. Blaha, B. Barteczko-Grajek, P. Berezowicz, J. Charvat, J. Chvojka, T. Grau, J. Holmgren, U. Jaschinski, P. Kopecky, J. Manak, M. Moehl, J. Paddle, M. Pasculli, J. Petersson, S. Petros, D. Radrizzani, V. Singh, J. Starkopf,
520    9_
$a BACKGROUND: Glycaemia control (GC) remains an important therapeutic goal in critically ill patients. The enhanced Model Predictive Control (eMPC) algorithm, which models the behaviour of blood glucose (BG) and insulin sensitivity in individual ICU patients with variable blood samples, is an effective, clinically proven computer based protocol successfully tested at multiple institutions on medical and surgical patients with different nutritional protocols. eMPC has been integrated into the B.Braun Space GlucoseControl system (SGC), which allows direct data communication between pumps and microprocessor. The present study was undertaken to assess the clinical performance and safety of the SGC for glycaemia control in critically ill patients under routine conditions in different ICU settings and with various nutritional protocols. METHODS: The study endpoints were the percentage of time the BG was within the target range 4.4 - 8.3 mmol.l(-1), the frequency of hypoglycaemic episodes, adherence to the advice of the SGC and BG measurement intervals. BG was monitored, and insulin was given as a continuous infusion according to the advice of the SGC. Nutritional management (enteral, parenteral or both) was carried out at the discretion of each centre. RESULTS: 17 centres from 9 European countries included a total of 508 patients, the median study time was 2.9 (1.9-6.1) days. The median (IQR) time-in-target was 83.0 (68.7-93.1) % of time with the mean proposed measurement interval 2.0 ± 0.5 hours. 99.6% of the SGC advices on insulin infusion rate were accepted by the user. Only 4 episodes (0.01% of all BG measurements) of severe hypoglycaemia <2.2 mmol.l(-1) in 4 patients occurred (0.8%; 95% CI 0.02-1.6%). CONCLUSION: Under routine conditions and under different nutritional protocols the Space GlucoseControl system with integrated eMPC algorithm has exhibited its suitability for glycaemia control in critically ill patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT01523665.
650    _2
$a senioři $7 D000368
650    _2
$a krevní glukóza $x účinky léků $x metabolismus $7 D001786
650    _2
$a péče o pacienty v kritickém stavu $x metody $7 D003422
650    _2
$a kritický stav $x terapie $7 D016638
650    12
$a systémy pro podporu klinického rozhodování $x přístrojové vybavení $7 D020000
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x aplikace a dávkování $7 D007328
650    12
$a jednotky intenzivní péče $7 D007362
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Barteczko-Grajek, Barbara $u Department of Anaesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw, Poland. bbgrajek@wp.pl.
700    1_
$a Berezowicz, Pawel $u Department of Anaesthesiology and Intensive Care Medicine, Vejle Hospital, Vejle, Denmark. pawel.stefan.berezowicz@slb.regionsyddanmark.dk.
700    1_
$a Charvat, Jiri $u Internal Medicine Clinic, University Hospital in Motol, Prague, Czech Republic. jiri.charvat@lfmotol.cuni.cz.
700    1_
$a Chvojka, Jiri $u Medical Department I, Faculty of Medicine in Pilsen, Charles University in Prague and University Hospital in Pilsen, Pilsen, Czech Republic. chvojkaj@fnplzen.cz.
700    1_
$a Grau, Teodoro $u Department of Anaesthesiology and Intensive Care Medicine, Capio Hospital Sur, Madrid, Spain. teograu@terra.com.
700    1_
$a Holmgren, Jonathan $u Department of Anaesthesiology and Intensive Care Medicine, County Hospital Ryhov, Jönköping, Sweden. jonathan.holmgren@lj.se.
700    1_
$a Jaschinski, Ulrich $u Department of Anaesthesiology and Surgical Intensive Care Medicine, Klinikum Augsburg, Augsburg, Germany. ulrich.jaschinski@klinikum-augsburg.de.
700    1_
$a Kopecky, Petr $u Department of Anaesthesiology and Intensive Medicine, 1st Faculty of Medicine, Charles University and General University Hospital Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. petr.kopecky@vfn.cz.
700    1_
$a Manak, Jan $u Department of Internal Medicine III - Metabolism and Gerontology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. manak@lfhk.cuni.cz.
700    1_
$a Moehl, Mette $u Department of Cardiothoracic Anaesthesia and Intensive Care Unit, University Hospital, University of Copenhagen, Copenhagen, Denmark. mmoehl@gmail.com.
700    1_
$a Paddle, Jonathan $u Intensive Care Department, Royal Cornwall Hospital, Truro, UK. jonathan.paddle@rcht.cornwall.nhs.uk.
700    1_
$a Pasculli, Marcello $u Department of Surgical and Intensive Medicine, Siena University Hospital, Siena, Italy. marcello.pasculli@hotmail.com.
700    1_
$a Petersson, Johan $u Department of Anesthesiology and Intensive Care, Karolinska University Hospital Solna, Stockholm, Sweden. johan.petersson@karolinska.se.
700    1_
$a Petros, Sirak $u Medical ICU, University Hospital Leipzig, Leipzig, Germany. sirak.petros@medizin.uni-leipzig.de.
700    1_
$a Radrizzani, Danilo $u Department of Anesthesiology and Intensive Care, Legnano Hospital, Legnano, Italy. danilo.radrizzani@gmail.com.
700    1_
$a Singh, Vinodkumar $u Critical Care Services, Department of Anaesthetics, West Suffollk Hospital NHS Trust, Bury St Edmunds, UK. vinod@uab.edu.
700    1_
$a Starkopf, Joel $u Department of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia. joel.starkopf@kliinikum.ee.
773    0_
$w MED00006769 $t BMC anesthesiology $x 1471-2253 $g Roč. 16, č. - (2016), s. 8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26801983 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170113095448 $b ABA008
999    __
$a ok $b bmc $g 1179730 $s 961157
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c - $d 8 $e 20160122 $i 1471-2253 $m BMC anesthesiology $n BMC Anesthesiol $x MED00006769
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...